
|Articles|March 1, 2010
- Pharmaceutical Executive-03-01-2010
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2010
Merck’s Man in Emerging Markets
Advertisement
Articles in this issue
over 15 years ago
JWTover 15 years ago
Sixth Annual Press Auditover 15 years ago
Stay Ahead of the Technology Curveover 15 years ago
E-Health to Drive Drug Safetyover 15 years ago
Echo Torre Lazurover 15 years ago
The Race Is Onover 15 years ago
MicroMassover 15 years ago
Saatchi & Saatchiover 15 years ago
Palioover 15 years ago
Moving Beyond Compliant Social MediaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
3
DEI Changes in Pharma: A Look Back at 2025 & Predictions for 2026
4
Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval
5





